Top 50 Biotech Startup Investors in Hong Kong in October 2024
A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Hong kong. We rank investors based on the number of investments they made in Biotech companies from Hong kong. We update this investor list every month.Top 50 Biotech Startup Investors in Hong Kong in October 2024
Loyal runs a global venture fund with quarterly redemptions and a proprietary gate-stage process, reducing investment bias and unlocking greater returns. Partnered with INSEAD, Founder Institute, and 500+ advisors, we are Loyal to the world with 250+ investments in 50+ countries.
Show more
Investment focus
- Artificial Intelligence, Software, E-Commerce
- Pre-Seed, Seed, Funding Round
- United States, Canada, United Kingdom
Portfolio highlights
- UTOBO INC. — utobo is the one-stop platform for educators and coaching services to take live classes, create courses and test series, and sell them online in just 30 minutes.
- NIU NIU — NIU NIU is an e-Waste operating system that maximizes critical mineral extraction, while minimizing the environmental and social impact
- The Leaf Protein Company — Unlocking Earth's most abundant source of proteins - green leaves.
Whist Subholdings is a venture capital investment firm.
Show more
Investment focus
- Medical, Agriculture, Biotechnology
- Seed, Funding Round
- Hong Kong
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
FHB Ventures is a venture capital firm.
Show more
Investment focus
- Medical, Agriculture, Biotechnology
- Seed, Series A, Series B
- Hong Kong, United States
Portfolio highlights
- EarthOptics — EarthOptics is building the cloud-based machine learning platform for soil and ground management.
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
PT Medion is a venture capital investment firm.
Show more
Investment focus
- Medical, Agriculture, Biotechnology
- Seed, Funding Round
- Hong Kong
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Series A, Pre-Seed
- Australia, United States, Hong Kong
Portfolio highlights
- Bygen — Bygen delivers high-quality activated carbon products while also facilitating large-scale, long-term carbon dioxide sequestration.
- Ohmie Go — EV charging solutions, shared electric vehicles, shared e-bikes & e-scooters delivered to residents as a premium managed service and amenity - An intelligent way to get EV ready with one seamless experience.
- Sova Health — Sova Health is a precision nutrition platform that guides users towards a healthier lifestyle with personalized nutrition advice based on accurate blood biomarker analysis. Understand what is stopping you from achieving your nutritional goal and get your personalized nutrition plan.
Simmons Foods is a leading supplier of poultry, pet and ingredient products based in Siloam Springs, Arkansas.
Show more
Investment focus
- Medical, Agriculture, Biotechnology
- Seed, Funding Round
- Hong Kong
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Welcome to Arkansas Development Finance Authority (ADFA), your source for safe, decent, affordable housing in Arkansas. Contact us at (501) 682-5900 to secure your dream home today!
Show more
Investment focus
- Medical, Biotechnology, Fashion
- Funding Round, Seed, Pre-Seed
- United States, Hong Kong
Portfolio highlights
- Ascendant Dx — Choose An Online Slot Game
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
- BlueOak Resources — BlueOak: Sourcing Metals Sustainably™ from End-of-Life Electronics.BlueOak believes in the philosophy of resource and capital efficiency. They are building distributed mini-refineries that use proven, capital-efficient refining processes towards extracting precious metals and rare earth elements from e-waste. Their vision is to revolutionize howwe treat end of life electronics: converting the e-waste of today into a sustainable source of critical metals and rare earths for the technologies of tomorrow.
Lever VC is a U.S.-Hong Kong venture capital fund founded by Managing Partner Nick Cooney and investing in early stage companies in the alternative protein sector (plant-based and “clean”/cell-based meat, egg and dairy companies). Lever VC operates globally, with offices in Hong Kong and the U.S. and staff in the US, Hong Kong, Europe, andIsrael. Entrepreneurs and startups interested in connecting with Lever VC about possible investment can reach the team and submit information about their company at http://www.levervc.com.Managing Partner Nick Cooney is the Co-Founder and former Managing Trustee of New Crop Capital, a private venture capital trust vehicle investing in the alternative protein space, and is Co-Founder of the Good Food Institute, the world’s largest non-governmental organization working to grow the alternative protein space. The General Partners at Lever VC have deployed over $1.5 billion in capital over the past decade across a variety of sectors, including over thirty deals in the alternative protein space.
Show more
Investment focus
- Food and Beverage, Biotechnology, Food Processing
- Seed, Series A, Pre-Seed
- United States, China, Brazil
Portfolio highlights
- THIS — THIS is a plant-based meat brand that provides alternative meat products for meat lovers. The company's products are made of plant-based ingredients that are fortified with vitamin B12 and iron, enabling meat lovers to get the real feel of having meat-based products and satisfy their tastes without killing animals.
- Bond Pet Foods — We make vegan and protein-rich pet food and treats formulated by board-certified veterinary nutritionists.
- Clever Carnivore — Clever Carnivore is a cell-cultured meat startup that uses stem cell biology, recombinant protein, and bioengineering to create cost-effective lab grown meats. With the company's high-efficiency model, cruelty-free, environmentally friendly, and cost-competitive technology it aims to produce sausage, burgers, and chicken nuggets.
A collection of entrepreneurs, engineers, physicists, doctors, surfers, and musicians who are committed to helping entrepreneurs achieve their dreams of changing the world.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Seed, Series B
- United States, Hong Kong, Canada
Portfolio highlights
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more
Investment focus
- Food and Beverage, Food Processing, Biotechnology
- Series A, Seed, Series B
- United States, Israel, United Kingdom
Portfolio highlights
- ENOUGH — ENOUGH makes protein sustainable by producing ABUNDA mycoprotein, made by fermenting fungi with the natural sugars from grains. It is a whole protein with all 9 essential amino acids & rich in fibre. It is a B2B ingredient, neutral in taste and fibrous in texture, like meat. The most sustainable
- PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
- Wanda Fish Technologies — Wanda Fish is an innovative FoodTech company with a platform that produces a wide variety of delicious fish fillets using sustainable cell-cultivation practices.
Gobi Partners GBA is part of the Pan-Asian venture capital platform Gobi Partners. Gobi GBA is the sole general partner (GP) of the Alibaba Hong Kong Entrepreneurs Fund (AEF) as well as the AEF Greater Bay Area Fund (AEF GBA Fund) and has formed strategic partnerships with other renowned financial institutions such as HSBC and Hang Seng Bank.Gobi GBA has invested in over 70 start-ups across the Greater Bay Area and has fostered the growth of 7 unicorns including Airwallex, Amber, Animoca Brands, GoGoX, Prenetics, and more.
Show more
Investment focus
- Biotechnology, Medical, Hospitality
- Seed, Angel, Series A
- Hong Kong, China
Portfolio highlights
- Immuno Cure — Immuno Cure, it is a biotechnology company it is specialized in the study and creation of immunotherapies for cancer, inflammatory, and infectious disorders.
- Guoke Ling Fiber — Guoke Ling Fiber focuses on technological research and industrialization of key materials for hydrogen fuel cells. Guoke offers carbon fiber base paper and carbon paper production lines.
- BioMed Technology Holdings — BioMed offer a comprehensive service that includes a range of sophisticated tests performed by professionals, together with an interpretation and recommendations for how to live a healthy life.
Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services.
Proxima Ventures was acquired by Soluto in October 2013.
Proxima Ventures was founded by Chaim Venezia and Uri Ra'anan and is based in Tel Aviv, Israel.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- China, United States, Israel
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- Yidianling — Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.
- Immune-Onc Therapeutics — Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Apis Partners LLP backs growth financial services innovators who create transformative impact in their communities.
Show more
Investment focus
- Financial Services, Payments, FinTech
- Private Equity, Series B, Funding Round
- India, Singapore, South Africa
Portfolio highlights
- TymeBank — TymeBank is a fully black-owned and controlled investment company based in South Africa. It is an exclusively digital retail bank that aims to provide every South African accessible and affordable banking so that they can take part in, grow and benefit from the country’s economy.
- Moneyview — Money View is an application that is able to track and organize expenses, bills, and account balances. It is able to derive finance information from SMSs.Money View enables its users to set and follow budgets, view their bank account balance, obtain reminders about bills, and spit bills with the other users. It also facilitates Savings+ andTaxSaver+ that allows its users to save money.Money View was founded in April 2014 by Sanjay Aggarwal and Puneet Agarwal. It is based in Bangalore, Karnataka.
- Peach Payments — Get Peach as your Payment Gateway and Grow your ecommerce. Process online payments with Visa, Mastercard, Debit Orders, EFT payments, and subscriptions. Plugins for Wix, Shopify, WooCommerce.
WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team
Show more
Investment focus
- Biotechnology, Health Care, Food and Beverage
- Series A, Seed, Series B
- United States, France, Denmark
Portfolio highlights
- EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
- Protealis — Sustainable plant proteins for Europe
- Clever Carnivore — Clever Carnivore is a cell-cultured meat startup that uses stem cell biology, recombinant protein, and bioengineering to create cost-effective lab grown meats. With the company's high-efficiency model, cruelty-free, environmentally friendly, and cost-competitive technology it aims to produce sausage, burgers, and chicken nuggets.
Capital Union Investments is a leader in private investment for early stage, growth, mezzanine, and pre-IPO capital. Headquartered in Hong Kong; and with offices in China and the US, the Firm's investment philosophy has been to create value by identifying leaders and innovators, whose businesses that can be developed in Asia. Our approach ofproviding unique investment insights, local knowledge and value-added operating capabilities, differentiates us from many traditional private investment funds.
Show more
Investment focus
- SaaS, Genetics, Software
- Seed, Series A
- Hong Kong, United States
Portfolio highlights
- Bringhub — Bringhub is a contextual marketing platform that enables digital media and marketers to drive product discovery and sales. We have developed the most comprehensive contextual analysis and optimization engine on the market. We call it Sweeten.
- Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
- Dash Living — Dash Living is the new generation of serviced living solutions in Asia Pacific. Offering 2,000+ furnished rooms for rent, including coliving homes, serviced apartments, hotel rooms etc.
Merrill Lynch Wealth Management has the financial advisors and expertise to help you achieve your goals at any stage of your life or career.
Show more
Investment focus
- Software, Information Technology, Internet
- Funding Round, Series B, Series C
- United States, India, United Kingdom
Portfolio highlights
- ITM Power — ITM manufacture PEM electrolysers. A pioneering technology that generates green hydrogen enabling customers to decarbonise.
- Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
- The Boeing Company — Welcome to the official corporate site for the world's largest aerospace company and leading manufacturer of commercial jetliners and defense, space and security systems. Learn about our passion for innovation, our products, careers and more.
China Venture Capital is a venture capital industry trade group.
Show more
Investment focus
- Manufacturing, Biotechnology, Information Technology
- Angel, Series B, Funding Round
- China, Hong Kong, United States
Portfolio highlights
- Borei Electric — Borei Electric is a company that produces advanced intelligent manufacturing equipment. It primarily services the semiconductor, new energy, and scientific research equipment markets.
- Yanming Biology — Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
- Dezhi New Materials — Dezhi New Materials is an equipment manufacturing company that specializes in silicon carbide nano-mirror coatings and ceramic matrix composite materials for semiconductor production.
A US$60M startup fund aiming at revitalizing HK’s ecosystem of innovation by connecting local venture capitalists and entrepreneurs to invest in ideas and startups. It is co-founded by Hony Capital, eGarden Ventures & several successful HK entrepreneur
Show more
Investment focus
- Artificial Intelligence, Information Technology, Health Care
- Seed, Series A, Funding Round
- Hong Kong, China, Canada
Portfolio highlights
- SpacemiT — SpacemiT is a computing chip company developing natively integrated cloud-edge-device architecture. It focuses on building RISC-V high-performance CPUs and providing computing solutions with integrated hardware and software optimization. The company's mission is to be the cornerstone of computing power in the digital age, driven to become asignificant global computing powerhouse.
- Springdel — Move beyond cloud and legacy MDM with an enterprise-grade EdgeOps platform purpose-built for the interactive Edge of Things.
- Yuchao Technology — Yuchao Technology is a digital collecting platform that uses blockchain technology to protect intellectual property.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Series C
- China, United States, India
Portfolio highlights
- Muyanzhiyu — Muyanzhiyu is a software development service provider that specializes in the creation of intelligent vehicle equipment, software development, and the production of basic artificial intelligence software.
- Silicon Box — We are an advanced chiplet interconnection company specialising in cutting-edge semiconductor integration services. Learn more about our proprietary integration technology.
- Global Data Solutions — Global Data Solutions designs, builds, and operates data centers in the People's Republic of China together with its subsidiaries. It provides colocation, managed hosting, and managed cloud services, as well as consulting services. Global Data Solutions's data centers service customers that primarily operate in the Internet and bankingindustries in Shanghai and Beijing municipalities; and Jiangsu, Guangdong, Sichuan, and Hebei Provinces. It serves cloud service providers, Internet companies, financial institutions, telecommunications and IT service providers, and large domestic private sector and multinational corporations. William Wei Huang founded Global Data Solutions in 2000. It has its headquarters in Shanghai in the People's Republic of China.
AEF Greater Bay Area Fund is an investment fund.
Show more
Investment focus
- Biotechnology, Sports, Sports Leagues and Teams
- Seed, Series A, Series B
- Hong Kong, Macao
Portfolio highlights
- ChaZence — ChaZence is an environmental consulting and biotechnology company that manufactures, innovates, and designs naturally degradable materials for a sustainable lifestyle.
- Realeague — Realeague is an organizer of sports entertainment designed to establish a cross-league basketball tournament in East Asia.
- Scolioscan — Scolioscan focuses on medical imaging technology research & development, self-service production and technology distribution and promotion.
The HK$2 billion ITVF was set up by the Hong Kong Government with a view to creating a vibrant local innovation and technology eco-systems
Show more
Investment focus
- Information Technology, Logistics, Financial Services
- Series A, Seed, Series B
- Hong Kong, China
Portfolio highlights
- Mezzofy — We provide a comprehensive Digital Coupon platform for the Business to create, to distribute, to redeem coupons. It is simpliest way ever, the merchant can create marketing campaigns with coupon, self help all the way, no technical help is needed.
- Qupital — Qupital helps e-commerce sellers with our Fintech, bringing them a financing solution that is easier to apply, more efficient and at a lower cost.
- Jumppoint — Founded in Hong Kong since 2020, Jumppoint developed in house its own multi-layer dynamic routing algorithm, jumppoint.ai, to offer highly efficient yet cost-saving logisitics services to B2B and B2C users, with real-time logisitcs data embeded. Beyond Hong Kong headquarters and R&D centre, Jumppoint also has extensive presence in Asia suchas Kuala Lumpur, Taipei and Southeast Asia headquarters, Singapore, providing localised logsitics services.
Longevity Vision Fund is a $100M investment fund dedicated to making longevity affordable and accessible to all. The fund accelerates longevity breakthroughs by investing in companies that develop technologies, products, and services that extend healthy human lifespans and overcome the negative effects of agingLongevity Vision Fund provides Seedto Series C funding to biotech and life extension-focused companies that have demonstrated affordable longevity potential and vision of milestones driving up the value of the company and market validation.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series C, Series A
- United States, Hong Kong, Isle of Man
Portfolio highlights
- Biolinq — Introducing a revolutionary platform for metabolic health.
- Senda Biosciences — We work at the frontier of programmable medicines. We power our bioplatform and product candidates by harnessing evolution and AI. We operate with purpose and urgency on behalf of people everywhere. We aim to generate life-changing impact for the world.
- Tessera Therapeutics — Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine,building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Human Longevity and Performance Impact Venture Fund is a longevity focused early-stage venture capital fund dedicated to providing resources, insight, and leadership to companies whose mission is to improve human health and drive longevity through technology, predictive analytics, research, and patient care. HLPIVF is establishing a synergisticecosystem of longevity and performance-focused companies to dramatically increase the volume and effectiveness of life-affirming diagnostics and therapeutics.
Show more
Investment focus
- Health Care, Biotechnology
- Series A
- Hong Kong
Portfolio highlights
- Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Founded in 2015, A-Level Capital is a student-run venture capital firm that aims to empower Johns Hopkins University's entrepreneurial community through funding and support.
Show more
Investment focus
- Health Care, Medical, SaaS
- Seed, Funding Round, Series A
- United States, Hong Kong
Portfolio highlights
- Order — Bring your procure-to-pay process into the 21st century with Order. Learn how automating purchasing & payment processes helps businesses save time, save money, and gain clarity into spend. (Formerly Negotiatus).
- Siren Care — Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Siren significantly improves patient outcomes and experience by augmenting traditional healthcare with tech-enabled clinical models to provide whole person care. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive servicepowered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers.
- Leap AI — Build powerful AI workflows in minutes.
The International Medical is an investment firm
Show more
Investment focus
- Medical, Hospitality, Biotechnology
- Seed
- Hong Kong
Portfolio highlights
- BioMed Technology Holdings — BioMed offer a comprehensive service that includes a range of sophisticated tests performed by professionals, together with an interpretation and recommendations for how to live a healthy life.
208 Seed Ventures provides early-stage investments in frontier technologies. 2SV brings Midwestern leaders, investors, and operators together and invests in startups pushing current technological limits. Their network provides smart capital and resources for companies with big ideas to accelerate growth.
Show more
Investment focus
- Biotechnology
- Seed
- Hong Kong
Portfolio highlights
- Avant Meats — They focus on technology, commercial product innovation, and branding as well as intellectual property portfolio building in the area of ‘cell-based’ animal protein food products.
Tiger Jade Capital is a Private Equity fund focused on global healthcare industry. It is a comprehensive healthcare fund covering new drugs, CRO, medical equipment, etc.
Show more
Investment focus
- Biopharma, Life Science, Biotechnology
- Series A
- Hong Kong
Portfolio highlights
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Empowering outstanding entrepreneurs across Southeast Asia in creating the next defining technology companies.
Show more
Investment focus
- E-Commerce, Health Care, Financial Services
- Series A, Seed, Series B
- Indonesia, Singapore, Vietnam
Portfolio highlights
- FR8Labs — Optimize your freight business with our AI Freight Forwarding Software. Boost efficiency and stay ahead in logistics.
- Saladin — Saladin is an online platform that provides life, health, automotive, and travel insurance services.
- Klinik Pintar — Klinik Pintar membantu pasien mendapatkan layanan kesehatan primer terbaik di klinik, rumah, dan kantor.
Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.
Show more
Investment focus
- Biotechnology, Health Care, Artificial Intelligence
- Seed, Series A, Funding Round
- United States, United Kingdom, Hong Kong
Portfolio highlights
- Turn.bio — Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered.Turn Biotechnologies surpasses traditional approaches based on single gene/pathway manipulations and tackles the multifaceted manifestation ofcellular age at the organ, tissue, and organismal level to extend the healthspan of people. As a result, age is reset by epigenetically reprogramming cells.
- cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
- Sampling Human — The mission of Sampling Human is to couple health related decisions to their effects at the single cell level. It is inspired by the founders’ academic and professional efforts to extend what is measurable and to derive what must be measured.The human body is a complex system that cannot be quantified exhaustively or heuristically. Clinicaldiagnosis today is an imprecise art. On average, diagnosis of rare diseases is 5 years delayed with 50% of delays impacting the outcome. Misdiagnosis is far too common with a 66% likelihood of disagreement between experts. We are stuck with symptoms based medicine.The nature of physiological data is to blame. Decisions today are based on fuzzy variables (tired, drowsy, weak, tingling, itchy, etc). Better decisions will require precise knowledge regarding the fundamental physiological units of our bodies, CELLS.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more
Investment focus
- Health Care, Wellness, Medical
- Seed, Funding Round, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
- Pear Suite — Pear Suite empowers community health workers with technology, education, and community, helping them do their best work and serve their communities.
- Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more
Investment focus
- Food and Beverage, Agriculture, Biotechnology
- Series A, Series B, Funding Round
- United States, Canada, Israel
Portfolio highlights
- Catalera — Catalera BioSolutions offers proprietary bio-based pest control products to enhance the well-being of people, plants, and planet.
- Exacto — Exacto is an innovative turnkey adjuvant manufacturer for agricultural, T&O and industrial vegetation management markets.
- Amperage — Amperage provides a full-service platform that focuses on directly investing and growing broadband infrastructure.
Good Startup is a venture firm focused on the alternative protein sector.
Show more
Investment focus
- Biotechnology, Food and Beverage, Food Processing
- Seed, Series A, Pre-Seed
- United States, France, Israel
Portfolio highlights
- Novel Farms — Novel Farms uses microbial fermentation to develop cruelty-free, inexpensive and tunable bioscaffolds for the production of cell-based meat products. Novel Farms mission is to craft the taste and texture of the gourmet meats and transform cell-based meat consumption into a sought-after culinary experience for the next generation of consciouseaters.
- Extracellular — Extracellular is a scale-up and development partner, channelling biology, digitalisation and biomanufacturing expertise to accelerate the potential of cultivated meat.
- Standing Ovation — Animal-free dairy cheese
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more
Investment focus
- Biotechnology, Health Care, Food and Beverage
- Series A, Seed, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Gobi Partners is the most interconnected Pan-Asian venture capital firm with US$1.5 billion in assets under management (AUM). Headquartered in Kuala Lumpur and Hong Kong, the firm supports entrepreneurs from the early to growth stages and focuses on emerging and underserved markets.Founded in 2002, Gobi has raised 15 funds to date, invested inover 350 startups and nurtured 10 unicorns. Gobi has grown to 15 locations across key markets in Bangkok, Beijing, Cairo, Guangzhou, Ho Chi Minh City, Hong Kong, Jakarta, Karachi, Kuala Lumpur, Lahore, Manila, Shanghai, Shenzhen, Singapore and Surabaya.As a Participant of the United Nations Global Compact, Gobi Partners is committed to aligning strategies and operations with universal principles on human rights, labour, environment and anti-corruption to ensure long-term value creation and sustainability across our portfolio.
Show more
Investment focus
- E-Commerce, Financial Services, Internet
- Series A, Seed, Series B
- China, Malaysia, Indonesia
Portfolio highlights
- Bateriku — Bateriku provides emergency roadside assistance for car breakdowns and car battery delivery in Malaysia with nationwide coverage. Learn more here!
- FinKnight — FinKnight offers new growth opportunities and financial management experience for companies. It bridges the gap by providing innovative financial leadership.
- Amity — Discover Amity, where we create digital solutions that help organizations, teams and individuals achieve more through technology and social innovation.
Particle Accelerator Limited (ParticleX) was founded in late 2017 by Shine Works. ParticleX is a tech-based startup investor and accelerator based in Hong Kong. ParticleX combines network, capital and research resources, accelerating the pace of innovative technology and helping the early-stage startups to win cross-border opportunities acrossAsia.
Show more
Investment focus
- Artificial Intelligence, Information Technology, Software
- Seed, Pre-Seed, Series A
- Hong Kong, United States, Singapore
Portfolio highlights
- Finquest — Tap into the largest private company database in the world to change the way you find and connect with M&A targets using Data, AI, & People.
- MediConCen — MediConCen is a medical network that mobilize medical experts all over the world to serve the insured population without middleman. They revolutionize the current medical network with Blockchain technology. MediConCen liberalizes the existing heavily walled medical network with the use of Blockchain technology, allowing individual clinics to rejointhe insurance market with a one-stop solution. The next generation medical ecosystem starts right here.MediConCen aims to integrate all clinics, insured employees and business entities into a unified Blockchain ecosystem, making business truly efficient, transparent and trustworthy.
- Crown Digital — Crown Digital harnesses the future-ready power of robotics and Artificial Intelligence to open doors with cutting-edge solutions for the not-so-distant future.
Provides growth equity to market leading companies in the United States and China
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Series B, Series A, Series C
- United States, Japan, Singapore
Portfolio highlights
- Rebellions — Under the latency critical mission in the age of Generative AI
- Lhoopa — Making homeownership achievable for every Filipino family.
- Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more
Investment focus
- FinTech, Financial Services, Artificial Intelligence
- Seed, Series A, Pre-Seed
- United States, Hong Kong, Singapore
Portfolio highlights
- Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
- Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
- MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Series A, Series B, Seed
- China, Singapore, Norway
Portfolio highlights
- Hyproof — Hyproof manufactures novel fluorine-containing materials for hydrogen energy and batch preparation technologies of hydrogen energy car fuel cells.
- Jingyuyimei — Jingyuyimei develops medical aesthetic materials and several new material subcutaneous injection filler products.
- Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
WI Harper Group is a venture capital firm that focuses on early and early expansion investments in Mainland China, Taiwan and Silicon Valley.It was founded in 1993. Made 300+ investments with 80+ exits. Manages 9 funds and over $1B in capital through 19 dedicated investment professionals located in Beijing, Taipei and San Francisco.Thefirm's focus is technology, clean technology and healthcare. Its track record includes
Show more
Investment focus
- Software, Health Care, Biotechnology
- Series A, Seed, Series B
- United States, Taiwan, China
Portfolio highlights
- GDMC — GDMC supports emergent growth companies and innovators in accelerating their genetic medicines to the clinic. We support the manufacturing of Viral Vectors, mRNA and plasmid DNA.
- Bitmark — Bitmark develops technology that secures the property rights of unique digital assets, without relying on trusted third parties.
- Blackpanda — Asia's premier digital forensics and cyber incident response firm.
Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providingsuperior returns to their investors.ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Funding Round, Series B, Series A
- China, United States, Hong Kong
Portfolio highlights
- Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
- Heranova Lifesciences — Hekaiwei is a provider of innovative solutions for women's health.
- Precision Autoimmune Therapeutics — Precision Autoimmune Therapeutics is a clinical-stage innovative drug development company focused on precision therapeutics for patients with autoimmune and inflammatory diseases.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more
Investment focus
- Biotechnology, Pharmaceutical, Health Care
- Series A, Series B, Series C
- United States, China, Israel
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
ETP Ventures
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Seed, Angel, Series A
- China, Hong Kong
Portfolio highlights
- SEIMEI — SEIMEI is a nutrition and anti-aging biotechnology brand.
- Dima Biotech — DIMA biotech has generated hundreds of the target specific B cell seed libraries and rabbit monoclonal antibodies (mAbs) against various druggable targets.
- Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies
Show more
Investment focus
- Biopharma, Life Science, Biotechnology
- Series A
- Hong Kong
Portfolio highlights
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Join the movement toward democratised private markets, where investing is open to everyone. Discover a range of vetted tech investments, embodying the spirit of innovation in Web3, FinTech, AI, and ESG. Transform your investment strategy for a smarter, more sustainable future.
Show more
Investment focus
- FinTech, Blockchain, Software
- Seed, Series A, Pre-Seed
- Hong Kong, United States, Israel
Portfolio highlights
- NeoSwap — NeoSwap is a multi-party, multi-item NFT swap platform that redistributes items in a win-win-win manner, using minimal currency. It provides neo-barter solutions to unlock value within existing marketplaces and enable marketplaces where they were previously unsustainable. It was founded by John Ennis.
- Antiverse — Designing biologics for 100 challenging targets
- HoyTrabajas — We are a C.Vs information exchange platform for candidates, employers, and recruiters, that get people access to low-skilled jobs in the Latin-American markets, enables recruiters to share job-seekers and job openings in real-time, and supports SMEs in the recruiting of their low-skilled jobs.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Funding Round, Seed, Series A
- China, United States, United Kingdom
Portfolio highlights
- Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.
Ping An Insurance Company is a holding company deals with insurance, banking, and financial service.
Show more
Investment focus
- Health Care, FinTech, Finance
- Series A, Series E, Funding Round
- China, United States, Japan
Portfolio highlights
- Lixiangjia — The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high networth families. Professional overseas asset reconfiguration plan.
- Biren Technology — Biren Technology is a high-tech startup that has the niche in softwares, hardwares, and chip system.The niche software department is led by the industry's top talents, composed of field technical experts and software elite engineers. The niche hardware department is committed to building a wide range of computing solutions based on generalcomputing, combining versatility and specificity.As a frontier research department of the niches, the Institute aims to study the key technologies of new intelligent computing systems, focusing on new architectures and advanced compilation technologies.
- Lenovo Healthcare Information Technology (Lenovo HIT) — Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.
Show more
Investment focus
- Biotechnology, Pharmaceutical, Health Care
- Funding Round, Series A, Debt Financing
- United States, Hong Kong, Isle of Man
Portfolio highlights
- LyGenesis — LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
- MDI Therapeutics — MDI Therapeutics is an operator of a discovery stage company focused on developing novel therapies for fibrotic diseases. The company have developed a proprietary discovery platform which has successfully identified novel small molecule and protein drug candidates, and have advanced these programs through key translational experiments usingclinical biomarkers.
- Souvien Therapeutics — Souvien Therapeutics is a biotechnology company focused on developing therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration.
Joel Neoh is the Founder and CEO of Fave. He attended Monash University.
Show more
Investment focus
- Apps, Mobile, Wellness
- Seed, Pre-Seed, Series A
- Malaysia, Hong Kong
Portfolio highlights
- KFit — KFit gets you into the best fitness studios, classes and gyms in your city. Get access to unlimited group fitness classes and activities with just one monthly membership. Transform your workouts.Never get bored. Discover new ways to move. Take as many classes per month as you’d like. Try a different studio everyday. It’s time to work out the wayyou want to.
- Ejen2u — Platform Sistem Pengurusan Ejen paling Komprehensif
- ULive — Live Commerce Enabler for Social Media Live Sellers.
With more than 30 portfolio companies across AI, pet health, ageing medicine and more, LongeVC provides venture capital for the biotech and longevity sectors.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Seed, Funding Round, Series A
- United States, Estonia, Hong Kong
Portfolio highlights
- Melio — Melio has created a rapid, precise, and comprehensive blood test that identifies 99% of the most common pathogens in hours, rather than days.
- Catena Biosciences — Catena Biosciences uses a novel protein conjugation method to bring breakthroughs in biological therapeutics, autoimmune disorders and vaccine development
- Interface Biosciences — At the interface of Human Biology and AI
Markus Haefeli is Chairman of PTG Food and Regal Springs.
Show more
Investment focus
- Biotechnology
- Seed
- Hong Kong
Portfolio highlights
- Avant Meats — They focus on technology, commercial product innovation, and branding as well as intellectual property portfolio building in the area of ‘cell-based’ animal protein food products.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Media (entertainment)
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Agriculture (agtech)
Sustainability
Beauty
Venture Capital
Social Media
Medical
Email
B2B
Art
Wellness
Music
Mobile
Franchise
Social Network
Local
Internet
Digital Media
Construction
Manufacturing
eSports
Sports
Enterprise Software
Legal
Android
Platforms
Mobile Advertising
Biotechnology
Hospitality
Fitness
Travel
Recruiting
Cannabis
Wine And Spirits
Medical Device
Crowdfunding
Social
Automotive
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
Photography
Finance
Real Estate
Big Data
LGBT
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Education
Payments
Fashion
Organic Food
Retail
Financial Services
Infrastructure
Sporting Goods
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Restaurants
Social Impact
Software
Facebook
Celebrity
Cryptocurrency
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Czech Republic
Morocco
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Gibraltar
Chile
Bermuda
Belize
Georgia
Greece
Egypt
Hungary
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Bulgaria
Bahrain
Turkey
Serbia
Rwanda
El Salvador
Malta
Venezuela
Ukraine
Portugal
Mali
Sierra Leone
Zimbabwe
Sweden
Malaysia
Taiwan
Senegal
Italy
Uruguay
Uganda
Tunisia
San Marino
Peru
Slovenia
Zambia
Uzbekistan
Russian Federation
Seychelles
Thailand
Lithuania
Puerto Rico
Tajikistan
Togo
Poland
Tanzania
Dominican Republic
Myanmar
Nigeria
Azerbaijan
Namibia
Iceland
Iraq
Bahamas
United Arab Emirates
Lebanon
Honduras
Kuwait
Bolivia
Isle of Man
Luxembourg
Cayman Islands
Albania
Pakistan
Cambodia
Israel
Panama
Grenada
Jordan
Romania
Argentina
Bangladesh
Mexico
Kazakhstan
Liberia
Jersey
Philippines
Norway
Mauritius
Kenya
Liechtenstein
Nicaragua
Latvia
Cyprus
Oman
Colombia
Austria
Cameroon
Switzerland
Guatemala
Marshall Islands
Investors in Hong Kong by industry
Restaurants
Social
Financial Services
Big Data
Cryptocurrency
Education
Organic Food
Finance
Payments
Food and Beverage
Medical
Fitness
Social Network
Agriculture (agtech)
Transportation
Social Media
Wellness
Art
Digital Media
Internet
Mobile
Blockchain
Construction
Software
Enterprise Software
Sports
eSports
Hospitality
Travel
Recruiting
InsurTech
Biotechnology
Platforms
FinTech
Enterprise
Consumer
Health Care
Biotech
EdTech
Energy
Climate
Impact
Sustainability
Manufacturing
Proptech
SaaS
Marketplace
Artificial intelligence
Community
Hardware
Gaming
Real Estate
Mobile Apps
Retail
Fashion
Life Science
B2B
Video Games
Web3
Clean Energy
Music
Media (entertainment)